Literature DB >> 6933845

Lymphoblastic leukemic transformation (lymphoblastic crisis) in myelofibrosis and myeloid metaplasia.

A Polliack, M Prokocimer, Y Matzner.   

Abstract

Acute lymphoblastic leukemia (ALL) developing in myelofibrosis (MF) and myeloid metaplasia (MM) is reported in two patients. In both cases, the clinical course of the "blastic crisis" was rapidly progressive with little response to chemotherapy. The circulating cells were readily identified as lymphoblasts on the basis of cytology, cytochemistry, immunologic studies, and ultrastructure. In one of the cases, 40% of cells had T-cell markers and all cells contained paranuclear acid phosphatase. In the second case, cells had a "Burkitt-like appearance, contained multiple cytoplasmic vacuoles positive for oil red O, and one-third of them had B-cell markers. The development of lymphoblastic crisis in MF and MM occurs rarely, is analogous to blastic transformation in chronic granulocytic leukemia, and supports the hypothesis that myeloproliferative disorders originate from pluripotent hematopoietic stem cells.

Entities:  

Mesh:

Year:  1980        PMID: 6933845     DOI: 10.1002/ajh.2830090209

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  10 in total

1.  Acute lymphoblastic leukemia arising in post-polycythemic myelofibrosis: a rare entity.

Authors:  Maro Ohanian; Vasiliki Leventaki; Srdan Verstovsek; Zeev Estrov; Pei Lin; Cameron Yin; Hagop Kantarjian; Yang Huh; Farhad Ravandi
Journal:  Leuk Lymphoma       Date:  2012-03-13

2.  Development of acute leukaemia after idiopathic myelofibrosis.

Authors:  J M Hernández; J F San Miguel; M González; A Orfao; M C Cañizo; C Bascones; J Hernández; A López Borrasca
Journal:  J Clin Pathol       Date:  1992-05       Impact factor: 3.411

3.  Acute Lymphoblastic Leukemia Transformation in Polycythemia Vera: A Rare Phenomenon.

Authors:  Władysław B Gaweł; Grzegorz Helbig; Kinga Boral; Sławomira Kyrcz-Krzemień
Journal:  Indian J Hematol Blood Transfus       Date:  2016-03-24       Impact factor: 0.900

4.  Acute Lymphoblastic Leukemia in the Course of Polycythemia Vera: A Case Report and Review of Literature.

Authors:  Dijiong Wu; Baodong Ye; Jianping Shen; Laijun Peng; Zhiqiang Zhong; Yuhong Zhou
Journal:  Indian J Hematol Blood Transfus       Date:  2015-09-21       Impact factor: 0.900

Review 5.  Extramedullary blastic transformation of primary myelofibrosis in the form of disseminated myeloid sarcoma: a case report and review of the literature.

Authors:  Giacomo Coltro; Francesco Mannelli; Federica Vergoni; Raffaella Santi; Daniela Massi; Luisa Margherita Siliani; Antonella Marzullo; Stefania Bonifacio; Elisabetta Pelo; Annalisa Pacilli; Chiara Paoli; Annalisa Franci; Laura Calabresi; Alberto Bosi; Alessandro Maria Vannucchi; Paola Guglielmelli
Journal:  Clin Exp Med       Date:  2020-02-17       Impact factor: 3.984

Review 6.  Bone biopsy in haematological disorders.

Authors:  R Burkhardt; B Frisch; R Bartl
Journal:  J Clin Pathol       Date:  1982-03       Impact factor: 3.411

Review 7.  Leukemic Transformation of Myeloproliferative Neoplasms: Therapeutic and Genomic Considerations.

Authors:  Bing Li; John O Mascarenhas; Raajit K Rampal
Journal:  Curr Hematol Malig Rep       Date:  2018-12       Impact factor: 3.952

8.  Primary myelofibrosis with concurrent precursor T-cell lymphoblastic lymphoma of the spleen in a 26-year-old patient.

Authors:  Matjaz Sever; Jeffrey L Jorgensen; Inga Gurevich; Mariana Pinheiro; Srdan Verstovsek
Journal:  Leuk Res       Date:  2009-05-30       Impact factor: 3.156

9.  Acute lymphoblastic leukemia secondary to myeloproliferative neoplasms or after lenalidomide exposure.

Authors:  Ahmad Alhuraiji; Kiran Naqvi; Yang O Huh; Coty Ho; Srdan Verstovsek; Prithviraj Bose
Journal:  Clin Case Rep       Date:  2017-12-06

Review 10.  Blast transformation and fibrotic progression in polycythemia vera and essential thrombocythemia: a literature review of incidence and risk factors.

Authors:  S Cerquozzi; A Tefferi
Journal:  Blood Cancer J       Date:  2015-11-13       Impact factor: 11.037

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.